多病共存加权指数与30天再入院及出院后死亡率的关联
结果显示MWI-ICD最高四分位者30天再入院风险显著增加,MWI-ICD每增加1分与30天再入院和365天死亡风险升高相关。
要点
- MWI-ICD最高四分位者30天再入院风险是最低四分位的1.92倍
- MWI-ICD每增加1分,30天再入院风险增加24%,365天死亡风险增加32%
- MWI-ICD最高四分位再入院者预期住院天数增加37%
核心结论
- 在Medicare受益人中,基于MWI-ICD的多病共存与再入院、死亡及住院时间延长风险增加相关。
- MWI-ICD是将躯体功能嵌入理赔数据的有效多病共存测量工具,可用于风险调整模型。
研究设计与样本
- 计算MWI-ICD(涵盖84种状况,按躯体功能加权),采用多因素logistic回归分析30、90、365天出院后死亡率,采用零膨胀负二项模型分析住院时间。
- 模型调整了年龄、性别、种族/民族、体质指数、吸烟状态、体力活动、教育、净资产及婚姻状况/居住安排。
主要发现
- 样本平均年龄75.9±8.7岁,平均MWI-ICD为14.9±9.0,20%发生30天再入院。
- MWI-ICD最高四分位与最低四分位相比,30天再入院比值比为1.92(95%CI:1.65-2.22)。
- MWI-ICD每增加1分,30天再入院比值比为1.24(95%CI:1.18-1.31),365天出院后死亡比值比为1.32(95%CI:1.25-1.40)。
- 再入院者中MWI-ICD最高四分位与最低四分位相比,预期住院天数的发生率比为1.37(95%CI:1.17-1.59)。
临床怎么用
- 可利用MWI-ICD识别再入院和死亡高风险的多病共存老年人,将躯体功能纳入理赔风险调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medically complex, disabled adults have high 30-day readmission rates. However, physical functioning is not routinely included in risk-adjustment models. We examined the association between multimorbidity with readmissions and mortality using a physical functioning weighted International Classification of Diseases (ICD)-coded multimorbidity-weighted index (MWI-ICD) representing 84 conditions. METHODS: We included Medicare beneficiaries with ≥1 hospitalization 2000-2015 who participated in a Health and Retirement Study interview before admission. We computed MWI-ICD by summing physical functioning weighted conditions from Medicare claims. We examined 30-, 90-, and 365-day postdischarge mortality using multivariable logistic regression and length of stay through zero-inflated negative binomials. Models adjusted for age, sex, race/ethnicity, body mass index, smoking status, physical activity, education, net worth, and marital status/living arrangement. RESULTS: The final sample of 10 737 participants had mean ± standard deviation (SD) age 75.9 ± 8.7 years, MWI-ICD 14.9 ± 9.0, and 20% had a 30-day readmission. Adults in the highest versus lowest quartile MWI-ICD had 92% increased odds of 30-day readmission (odds ratio [OR] = 1.92, 95% confidence interval [CI]: 1.65-2.22). A 1-point increase in MWI-ICD was associated with 24% increased odds of 30-day readmission (OR = 1.24, 95% CI: 1.18-1.31). A 1-point increase in MWI-ICD was associated with 32% increased odds of death within 365-day postdischarge (OR = 1.32, 95% CI: 1.25-1.40). Readmitted participants with the highest versus lowest quartile MWI-ICD had 37% increased number of expected hospitalized days (incidence rate ratio = 1.37, 95% CI: 1.17-1.59). CONCLUSION: Among Medicare beneficiaries, multimorbidity using MWI-ICD is associated with an increased risk of readmissions, mortality, and longer length of stay. MWI-ICD appears to be a valid measure of multimorbidity that embeds physical functioning and presents an opportunity to incorporate functional status into claims-based risk-adjustment models.
引用
- Wei MY. Multimorbidity, 30-Day Readmissions, and Postdischarge Mortality Among Medicare Beneficiaries Using a New ICD-Coded Multimorbidity-Weighted Index. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36480692. doi:10.1093/gerona/glac242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。